Actively Recruiting
Risk Factors That Increase the Chance of Developing Primary Graft Dysfunction After Lung Transplantation
Led by University of Pennsylvania · Updated on 2025-07-16
1150
Participants Needed
1
Research Sites
965 weeks
Total Duration
On this page
Sponsors
U
University of Pennsylvania
Lead Sponsor
N
National Heart, Lung, and Blood Institute (NHLBI)
Collaborating Sponsor
AI-Summary
What this Trial Is About
Primary graft dysfunction (PGD) is a severe lung complication that can occur in the days after lung transplant surgery. This study will analyze blood samples to determine if high levels of certain chemicals may increase the risk of developing PGD after a lung transplant.
CONDITIONS
Official Title
Risk Factors That Increase the Chance of Developing Primary Graft Dysfunction After Lung Transplantation
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Undergoing lung or combined heart and lung transplantation
You will not qualify if you...
- Undergoing combined organ transplantation other than heart and lung transplantation
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Pennsylvania
Philadelphia, Pennsylvania, United States, 19104
Actively Recruiting
Research Team
E
E.J. Demissie, MSN
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here